The levels of pro-inflammatory interleukin IL-18 are also elevated in obese subjects, and simultaneous treatment with IL-12 and IL-18 causes severe acute pancreatitis in obese mice but only edematous pancreatitis in control mice [14]. Here, IL18 is linked to pancreatitis.